Last reviewed · How we verify
Gastro-esophageal reflux disease with esophagitis
Approved treatments
- Protecadin
Protecadin works by blocking histamine H2 receptors to reduce stomach acid production. - Revanex
- CAMOSTAT
CAMOSTAT works by blocking the activity of hepsin, a protease that contributes to inflammation and tissue damage. - Takecab · Genuine Research Center, Egypt
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Gastro-esophageal reflux disease with esophagitis patent landscape — cliff calendar, originator estates, attackable patents
- Gastro-esophageal reflux disease with esophagitis treatment landscape brief
- Gastro-esophageal reflux disease with esophagitis treatment updates RSS
Frequently asked questions about Gastro-esophageal reflux disease with esophagitis
What drugs treat Gastro-esophageal reflux disease with esophagitis?
Tracked treatments include Protecadin, Revanex, CAMOSTAT, Takecab.
What is the treatment for Gastro-esophageal reflux disease with esophagitis?
Standard treatment for Gastro-esophageal reflux disease with esophagitis includes Protecadin, Revanex, CAMOSTAT, Takecab. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Gastro-esophageal reflux disease with esophagitis patent cliff · Gastro-esophageal reflux disease with esophagitis CI report
- Treatment: Protecadin
- Treatment: Revanex
- Treatment: CAMOSTAT
- Treatment: Takecab · Genuine Research Center, Egypt
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing